Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral: Vanier Canada Graduate Scholarships

University of Toronto

$100,000.00

Immunogenetic influences on the clinical phenotype of ankylosing spondylitis

FY 2009-10

Summary
Background: Patient with ankylosing spondylitis (AS) suffer from severe pain, systemic symptoms and progressive abnormal posture leading to work loss and decreased quality of life. HLA-B27 remains the gene with the strongest disease association. Recently, a genome-wide study discovered ERAP1, a new gene associated with AS, but there is no evidence of how it contributes to the pathogenesis. This novel finding is a likely long-sought missing link in understanding the mechanism of AS. Work already done: We genotyped 199 families that had two or more family members with AS and found one ERAP1 polymorphism and a novel ERAP1/ERAP2 haplotype to be associated with AS. Using blood samples from 80 AS patients, I examined and found no impact of these genes on the level of receptors for inflammatory factors. I discovered that a polymorphism in ERAP1 leads to significant differences in the surface free heavy chain expression on monocytes. Surface MHC expression is a surrogate marker for peptide processing and this novel finding could reflect abnormal peptide processing. This is first time that a functional relevance has been described for this particular polymorphism of ERAP1. Proposed Work: The spondylitis clinic at the Toronto Western Hospital is one of the few centers in the world with the ability to combine a strong clinical database with bench research to get excellent genotype-phenotype correlations. I propose to recruit 150 patients with sequential radiographs over the next 2 years. Assessments and radiographic scoring will be done using standardized measures. The effect of ERAP1/ERAP2 variants on the severity, activity, progression and response to treatment will be assessed. This could might help identify patient subsets with a different clinical course or treatment response, and thus help guide in disease management of AS. A series of bench experiments have been designed to look at the peptide processing pathway and the effect of ERAP1/ERAP2 variants.
Program
Doctoral: Vanier Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
197231
Name
Haroon Nigil
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Immunogenetic influences on the clinical phenotype of ankylosing spondylitis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Antigen Presentation; Functional Genomics; Hla B27; Immunology
Abstract
Background: Patient with ankylosing spondylitis (AS) suffer from severe pain, systemic symptoms and progressive abnormal posture leading to work loss and decreased quality of life. HLA-B27 remains the gene with the strongest disease association. Recently, a genome-wide study discovered ERAP1, a new gene associated with AS, but there is no evidence of how it contributes to the pathogenesis. This novel finding is a likely long-sought missing link in understanding the mechanism of AS. Work already done: We genotyped 199 families that had two or more family members with AS and found one ERAP1 polymorphism and a novel ERAP1/ERAP2 haplotype to be associated with AS. Using blood samples from 80 AS patients, I examined and found no impact of these genes on the level of receptors for inflammatory factors. I discovered that a polymorphism in ERAP1 leads to significant differences in the surface free heavy chain expression on monocytes. Surface MHC expression is a surrogate marker for peptide processing and this novel finding could reflect abnormal peptide processing. This is first time that a functional relevance has been described for this particular polymorphism of ERAP1. Proposed Work: The spondylitis clinic at the Toronto Western Hospital is one of the few centers in the world with the ability to combine a strong clinical database with bench research to get excellent genotype-phenotype correlations. I propose to recruit 150 patients with sequential radiographs over the next 2 years. Assessments and radiographic scoring will be done using standardized measures. The effect of ERAP1/ERAP2 variants on the severity, activity, progression and response to treatment will be assessed. This could might help identify patient subsets with a different clinical course or treatment response, and thus help guide in disease management of AS. A series of bench experiments have been designed to look at the peptide processing pathway and the effect of ERAP1/ERAP2 variants.
Competitiondate
200911
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Haroon, Nigil
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $100,000~ $0~